Malte Kluger
Priv.-Doz. Dr. med.
Malte A. Kluger
  • Medical Specialist in Internal Medicine and Nephrology
  • Medical Specialist in Internal Medicine
  • Transplant Medicine
  • Immunology
  • Working area 1
Languages
German (Mother tongue)
Danish
Dutch
French
English

Areas of expertise

Awards

Memberships

Publications

Zurück
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2009
  • 2008
  • 2005
Vor

The CCR6/CCL20 Axis Expands RORγt+ Tregs to Protect from Glomerulonephritis
Herrnstadt G, Niehus C, Ramcke T, Hagenstein J, Ehnold L, Nosko A, Warkotsch M, Feindt F, Melderis S, Paust H, Sivayoganathan V, Jauch-Speer S, Wong M, Indenbirken D, Krebs C, Huber T, Panzer U, Puelles V, Kluger M, Steinmetz O
KIDNEY INT. 2023;104(1):74-89.

Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation
Ghandili S, Kluger M, Leitner T, Grahammer F, Kirchner L, Modemann F, Achilles E, Kreipe H, Klein J, Steinemann D, Wolschke C, Fischer L, Bokemeyer C, Fiedler W, Huber T, Alsdorf W, Mahmud M
BRIT J HAEMATOL. 2022;198(1):199-202.

Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome
Schmidt T, Gödel M, Mahmud M, Fischer L, Huber T, Kluger M, Grahammer F
TRANSPLANT DIRECT. 2022;8(2):e1289.

Life-threatening complications of excessive licorice consumption—a case series from intensive care in a single center
Bangert K, Kluger M, Kluge S, Janneck M
DTSCH ARZTEBL INT. 2021;118(51-52):890-891.

Convalescent plasma treatment for early post-kidney-transplant acquired COVID-19
Kluger M, Czogalla J, Schmidt-Lauber C, Peine S, Schmiedel S, Bangert K, Kluge S, Huber S, Puelles V, Fischer L, Huber T, Grahammer F
TRANSPL INFECT DIS. 2021;23(4):e13685.

Early Manifestation of Post-Transplantation Leukemia Due to an Initial EBV Infection in a Kidney Transplant Recipient
Grahammer F, Mahmud M, Kluger M
DTSCH ARZTEBL INT. 2020;117(13):223.

A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity
Hagenstein J, Melderis S, Nosko A, Warkotsch M, Richter J, Ramcke T, Herrnstadt G, Scheller J, Yan I, Mittrücker H, Kluger M, Steinmetz O
J AM SOC NEPHROL. 2019;30(8):1439-1453.

IL-10 Receptor Signaling Empowers Regulatory T Cells to Control Th17 Responses and Protect from GN
Diefenhardt P, Nosko A, Kluger M, Richter J, Wegscheid C, Kobayashi Y, Tiegs G, Huber S, Flavell R, Stahl R, Steinmetz O
J AM SOC NEPHROL. 2018;29(7):1825-1837.

Kreatininanstieg in der Frühphase nach Nierentransplantation: Es muss nicht immer Abstoßung sein …
Kluger M, Person F, Wenzel U, Steinmetz O
NEPHROLOGE. 2018;13(1):37-40.

RORγt expression in Tregs promotes systemic lupus erythematosus via IL-17 secretion, alteration of Treg phenotype and suppression of Th2 responses
Kluger M, Nosko A, Ramcke T, Goerke B, Meyer M, Wegscheid C, Luig M, Tiegs G, Stahl R, Steinmetz O
CLIN EXP IMMUNOL. 2017;188(1):63-78.

T-Bet Enhances Regulatory T Cell Fitness and Directs Control of Th1 Responses in Crescentic GN
Nosko A, Kluger M, Diefenhardt P, Melderis S, Wegscheid C, Tiegs G, Stahl R, Panzer U, Steinmetz O
J AM SOC NEPHROL. 2017;28(1):185-196.

ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap
Anders H, Rovin B, Jayne D, Brunetta P, Coppo R, Davidson A, Devarapu S, de Zeeuw D, Duffield J, Eulberg D, Fierro A, Floege J, Frese S, Guillevin L, Holdsworth S, Hughes J, Kettritz R, Kluger M, Krebs C, Lapteva L, Levin A, Li J, Lightstone L, Mack M, Mansouri L, McAdoo S, McKinney E, Panzer U, Parikh S, Pusey C, Putterman C, Rabelink T, Radbruch A, Rees A, Reilly M, Reinders M, Remuzzi G, Ruggenenti P, Sacks S, Schall T, Meyer-Schwesinger C, Sharma K, Suzuki Y, Tomas N, Zhao M
KIDNEY INT REP. 2016;1(4):327-339.

Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
Kluger M, Melderis S, Nosko A, Goerke B, Luig M, Meyer M, Turner J, Meyer-Schwesinger C, Wegscheid C, Tiegs G, Stahl R, Panzer U, Steinmetz O
KIDNEY INT. 2016;89(1):158-166.

The Authors Reply to Letter to the Editor (Kidder D), referring to: Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus
Kluger M, Melderis S, Steinmetz O
KIDNEY INT. 2016;90(1):222-3.

RORγt+Foxp3+ Cells are an Independent Bifunctional Regulatory T Cell Lineage and Mediate Crescentic GN
Kluger M, Meyer M, Nosko A, Goerke B, Luig M, Wegscheid C, Tiegs G, Stahl R, Panzer U, Steinmetz O
J AM SOC NEPHROL. 2016;27(2):454-465.

IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases
Riedel J, Paust H, Krohn S, Turner J, Kluger M, Steinmetz O, Krebs C, Stahl R, Panzer U
J AM SOC NEPHROL. 2016;27(12):3666-3677.

Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN
Luig M, Kluger M, Goerke B, Meyer M, Nosko A, Yan I, Scheller J, Mittrücker H, Rose-John S, Stahl R, Panzer U, Steinmetz O
J AM SOC NEPHROL. 2015;26(7):1597-1607.

Stat3 Programs Th17-Specific Regulatory T Cells to Control GN
Kluger M, Luig M, Wegscheid C, Goerke B, Paust H, Brix S, Yan I, Mittrücker H, Hagl B, Renner E, Tiegs G, Wiech T, Stahl R, Panzer U, Steinmetz O
J AM SOC NEPHROL. 2014;25(6):1291-302.

B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis
Kluger M, Ostmann A, Luig M, Meyer M, Goerke B, Paust H, Meyer-Schwesinger C, Stahl R, Panzer U, Tiegs G, Steinmetz O
EUR J IMMUNOL. 2014;44(3):683-693.

Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis
Kluger M, Zahner G, Paust H, Schaper M, Magnus T, Panzer U, Stahl R
KIDNEY INT. 2013;83(5):865-77.

Prostaglandin EP2 and EP4 receptors modulate CCL2 (MCP-1) expression in response to LPS-induced renal glomerular inflammation.
Zahner G, Schaper M, Panzer U, Kluger M, Stahl R, Thaiss F, Schneider A
BIOCHEM J. 2009.

Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation
Zahner G, Schaper M, Panzer U, Kluger M, Stahl R, Thaiss F, Schneider A
BIOCHEM J. 2009;422(3):563-70.

Apoprotein A-V: An important regulator of triglyceride metabolism
Kluger M, Heeren J, Merkel M
J INHERIT METAB DIS. 2008;31(2):281-8.

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio L, Laatsch A, Heeren J
J BIOL CHEM. 2005;280(22):21553-21560.

Letzte Aktualisierung aus dem FIS: 26.12.2024 - 03:57 Uhr